Molecular mechanism of poliovirus Sabin vaccine strain attenuation

被引:12
|
作者
Avanzino, Brian C. [1 ]
Jue, Helen [1 ]
Miller, Clare M. [2 ]
Cheung, Emily [2 ]
Fuchs, Gabriele [2 ]
Fraser, Christopher S. [1 ]
机构
[1] Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, Davis, CA 95616 USA
[2] SUNY Albany, Dept Biol Sci, RNA Inst, Albany, NY 12222 USA
基金
美国国家卫生研究院;
关键词
poliovirus; eukaryotic translation initiation factor 4G (eIF4G); eukaryotic initiation factor 4A (eIF4A); RNA-binding protein; eukaryotic translation initiation; plus-stranded RNA virus; internal ribosome entry site (IRES); vaccine; virulence; TRACT-BINDING-PROTEIN; INTERNAL RIBOSOME ENTRY; HUMAN NEUROBLASTOMA; ATPASE ACTIVITIES; NONCODING REGION; HELICASE EIF4A; TRANSLATION; INITIATION; RNA; TYPE-3;
D O I
10.1074/jbc.RA118.004913
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recruitment of poliovirus (PV) RNA to the human ribosome requires the coordinated interaction of the viral internal ribosome entry site (IRES) and several host cellular initiation factors and IRES trans-acting factors (ITAFs). Attenuated PV Sabin strains contain point mutations in the PV IRES domain V (dV) that inhibit viral translation. Remarkably, attenuation is most apparent in cells of the central nervous system, but the molecular basis to explain this is poorly understood. The dV contains binding sites for eukaryotic initiation factor 4G (eIF4G) and polypyrimidine tract-binding protein (PTB). Impaired binding of these proteins to the mutant IRESs has been observed, but these effects have not been quantitated. We used a fluorescence anisotropy assay to reveal that the Sabin mutants reduce the equilibrium dissociation constants of eIF4G and PTB to the PV IRES by up to 6-fold. Using the most inhibitory Sabin 3 mutant, we used a real-time fluorescence helicase assay to show that the apparent affinity of an active eIF4G/4A/4B helicase complex for the IRES is reduced by 2.5-fold. The Sabin 3 mutant did not alter the maximum rate of eIF4A-dependent helicase activity, suggesting that this mutant primarily reduces the affinity, rather than activity, of the unwinding complex. To confirm this affinity model of attenuation, we show that eIF4G overexpression in HeLa cells overcomes the attenuation of a Sabin 3 mutant PV-luciferase replicon. Our study provides a quantitative framework for understanding the mechanism of PV Sabin attenuation and provides an explanation for the previously observed cell type-specific translational attenuation.
引用
收藏
页码:15471 / 15482
页数:12
相关论文
共 50 条
  • [41] Development of inactivated poliovirus vaccine from Sabin strains: A progress report
    Okayasu, Hiromasa
    Sein, Carolyn
    Hamidi, Ahd
    Bakker, Wilfried A. M.
    Sutter, Roland W.
    BIOLOGICALS, 2016, 44 (06) : 581 - 587
  • [42] Cooperative effect of the attenuation determinants derived from poliovirus Sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model
    Arita, Minetaro
    Ami, Yasushi
    Wakita, Takaji
    Shimizu, Hiroyuki
    JOURNAL OF VIROLOGY, 2008, 82 (04) : 1787 - 1797
  • [43] IDENTIFICATION OF A CONSISTENT PATTERN OF MUTATIONS IN NEUROVIRULENT VARIANTS DERIVED FROM THE SABIN VACCINE STRAIN OF POLIOVIRUS TYPE-2
    EQUESTRE, M
    GENOVESE, D
    CAVALIERI, F
    FIORE, L
    SANTORO, R
    BERCOFF, RP
    JOURNAL OF VIROLOGY, 1991, 65 (05) : 2707 - 2710
  • [44] AN INFECTIOUS CDNA CLONE OF THE POLIOVIRUS SABIN STRAIN COULD BE USED AS A STABLE REPOSITORY AND INOCULUM FOR THE ORAL POLIO LIVE VACCINE
    KOHARA, M
    ABE, S
    KUGE, S
    SEMLER, BL
    KOMATSU, T
    ARITA, M
    ITOH, H
    NOMOTO, A
    VIROLOGY, 1986, 151 (01) : 21 - 30
  • [45] Paralytic poliomyelitis associated with the Sabin 3 revertant strain of poliovirus in Bahrain
    Khalfan, SA
    Chomel, JJ
    Mallet, L
    Fernandes, E
    Lahlou, AI
    Lina, B
    Aymard, M
    ANNALS OF TROPICAL PAEDIATRICS, 2001, 21 (03): : 223 - 229
  • [46] Mechanism of action at molecular level of 3(2H)-isoflavene on poliovirus type 2 Sabin
    Salvati, AL
    De Dominicis, A
    Canitano, A
    Tait, S
    Fiore, L
    ANTIVIRAL RESEARCH, 2002, 53 (03) : A77 - A77
  • [47] POLIOVIRUS ANTIBODY 2 YEARS AFTER ORAL TRIVALENT VACCINE ( SABIN STRAINS )
    CABASSO, VJ
    COX, HR
    RUEGSEGGER, JM
    NOZELL, H
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1964, 190 (03): : 248 - &
  • [48] POLIOVIRUS ANTIBODY 3 YEARS AFTER ORAL TRIVALENT VACCINE (SABIN STRAINS)
    CABASSO, VJ
    NOZELL, H
    RUEGSEGGER, JM
    COX, HR
    JOURNAL OF PEDIATRICS, 1966, 68 (02): : 199 - +
  • [49] EVALUATION OF SABIN LIVE POLIOVIRUS VACCINE IN JAPAN .1. GENERAL PREFACE
    SAITO, K
    JAPANESE JOURNAL OF MEDICAL SCIENCE & BIOLOGY, 1966, 19 (06): : 269 - &
  • [50] 1ST CLINICAL-TRIAL WITH SABIN INACTIVATED POLIOVIRUS VACCINE
    MURPH, JR
    GROSE, C
    CUTHBERTSON, G
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1987, 141 (04): : 381 - 381